Publikation

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression.

Wissenschaftlicher Artikel/Review - 13.01.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Stallhofer J, Veith L, Diegelmann J, Probst P, Brand S, Schnitzler F, Olszak T, Török H, Mayerle J, Stallmach A, Beigel F. Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. Clin Transl Gastroenterol 2022; 13:e00450.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Clin Transl Gastroenterol 2022; 13
Veröffentlichungsdatum
13.01.2022
eISSN (Online)
2155-384X
Seiten
e00450
Kurzbeschreibung/Zielsetzung

Iron deficiency and vitamin D deficiency are common comorbidities in inflammatory bowel disease (IBD). Accumulating evidence indicates that active 1,25-dihydroxyvitamin D (1,25(OH)D) may enhance iron absorption by suppressing hepcidin. We investigated the influence of vitamin D on iron metabolism in patients with IBD and on the expression of genes facilitating intestinal epithelial iron absorption.